Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in Japan

Documenti analoghi

• Factors affecting the sodium‐glucose cotransporter 2 inhibitors‐related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database
  di: Tomohiko Kanaoka, et al.
  Pubblicazione: (2024)
• Erythropoiesis and estimated fluid volume regulation following initiation of ipragliflozin treatment in patients with type 2 diabetes mellitus and chronic kidney disease: A post‐hoc analysis of the PROCEED trial
  di: Tatsuya Maruhashi, et al.
  Pubblicazione: (2024)
• Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study
  di: Lijun Zhao, et al.
  Pubblicazione: (2024)
• Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset
  di: Hannah Wallace, et al.
  Pubblicazione: (2026)
• Baseline and 4‐year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort
  di: Aitziber Izarra, et al.
  Pubblicazione: (2026)